The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Oral Biologics & Biosimilars Market Progress Through 2030?
The oral biologics & biosimilars market size has seen substantial growth recently. It is projected to increase from $9.37 billion in 2025 to $11.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.3%. The expansion observed in prior periods was driven by the limited availability of oral biologics, the high cost associated with biologic therapies, a reliance on injectable formulations, the increasing prevalence of chronic diseases, and the growing networks of hospitals and retail pharmacies.
The oral biologics & biosimilars market size is projected to experience significant expansion in the coming years. Its value is anticipated to reach $24.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.6%. This forecasted growth is attributable to advancements in biosimilars and combination therapies, the enlargement of oral biologics pipelines, a greater patient inclination for oral drug delivery, increased use of digital adherence instruments, and enhanced government backing coupled with favorable reimbursement frameworks. Key trends expected during this period encompass the growing acceptance of oral biologics and biosimilars for managing chronic conditions, an increase in targeted therapeutic approaches for diabetes, arthritis, and cancer, the accelerated creation of monoclonal antibody-derived oral treatments, the broadening of distribution networks through hospitals, retail outlets, and online pharmacies, and a strong emphasis on ensuring patient compliance and tailoring treatment strategies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6830&type=smp
What Influential Factors Are Boosting The Oral Biologics & Biosimilars Market Demand?
The increasing incidence of long-term health issues is anticipated to fuel expansion within the oral biologics and biosimilar market moving ahead. These enduring medical ailments, which generally develop gradually, include conditions like diabetes, cardiovascular diseases, and respiratory disorders. Sedentary lifestyles are a primary contributor to the increase in chronic diseases, given that extended periods of physical inactivity elevate the likelihood of developing obesity, heart disease, type 2 diabetes, and specific types of cancer. Oral biologics and biosimilars facilitate this trend by offering patients managing chronic conditions treatment alternatives that are more accessible, economical, and convenient. To illustrate, data from January 2023, provided by the Centers for Disease Control and Prevention (CDC), a US-based federal agency, showed that in 2023, 76.4% of U.S. adults (approximately 194 million people) indicated they had at least one chronic condition. The prevalence rates were 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the growing incidence of chronic diseases is fueling the expansion of the oral biologics and biosimilar market.
How Does Segment Analysis Break Down The Oral Biologics & Biosimilars Market Structure?
The oral biologics & biosimilars market covered in this report is segmented –
1) By Therapy: Lymphocyte Modulators, Immunostimulants, GPCR Modulators, Other Therapies
2) By Disease: Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases
3) By Molecule Type: Vaccines, Proteins and Peptides, Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Lymphocyte Modulators: T-Cell Modulators, B-Cell Modulators, Sphingosine-1-Phosphate Receptor Modulators
2) By Immunostimulants: Cytokines, Immune Checkpoint Inhibitors, Adjuvants
3) By GPCR Modulators: Agonists, Antagonists, Biased Ligands
4) By Other Therapies: Cell-Based Therapies, Gene Therapies, Combination Therapies
What Trends Are Affecting The Growth Of The Oral Biologics & Biosimilars Market?
Major companies operating in the oral biologics & biosimilars market are prioritizing the creation of innovative solutions, such as tailored smart capsule development services, to enhance the oral delivery of biologics, boost bioavailability, and provide patient-friendly administration in contrast to traditional injectable formulations. These smart capsules incorporate advanced coatings, controlled-release matrices, or protective excipients that shield biologics from degradation within the gastrointestinal tract and optimize absorption in specific intestinal regions, presenting a non-invasive alternative to injections and improving patient adherence. An example is Lonza Group AG, a Switzerland-based contract development and manufacturing organization (CDMO), which unveiled a tailored service for smart capsule development in December 2024, specifically supporting oral biologics development. This service encompasses customized formulation design, protective excipient selection, and precise capsule engineering to ensure the stability and targeted release of biologics; it operates by enhancing the oral bioavailability of sensitive biomolecules while maintaining therapeutic efficacy; unique attributes include comprehensive support from initial concept to preclinical testing, compatibility with various biologic modalities (such as proteins, peptides, and nucleic acids), and scalable manufacturing solutions; its applications span the oral delivery of monoclonal antibodies, therapeutic peptides, and vaccines; benefits comprise improved patient convenience, reduced reliance on injections, enhanced compliance, and accelerated development timelines for oral biologic therapies.
Who Are The Firms Contributing To The Oral Biologics & Biosimilars Market Ecosystem?
Major companies operating in the oral biologics & biosimilars market are Merck & Co. Inc., GlaxoSmithKline, Novo Nordisk, BiosanaPharma, AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi, Microgen, Geropharm, Valenta, NovaMedica, SynBio, Roche, Rani Therapeutics, Eli Lilly and Company, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Abbvie, Johnson & Johnson, Pfizer Inc., Biogen Inc., Aché, Eurofarma, Teva Pharmaceuticals, Oramed Pharmaceuticals, Entera Bio, Julphar, Hikma Pharmaceuticals, Altis Biologics, Cipla Medpro South Africa, Genzyme
Access The Complete Oral Biologics & Biosimilars Market Report:
Which Regional Market Leads The Oral Biologics & Biosimilars Market?
North America was the largest region in the oral biologics and biosimilar drugs market in 2025. The Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in the oral biologics & biosimilars market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Oral Biologics & Biosimilars Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=6830&type=smp
Browse Through More Reports Similar to the Global Oral Biologics & Biosimilars Market 2026, By The Business Research Company
Dermatology Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report
Hematology Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Central Nervous System Drug Market Report 2026
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model